多种临床和病理现象的发病因子在多变性心肌病变的多样性
1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. amarian@bcm.tmc.edu
Lancet (London, England)
|January 1, 2000
概括
心脏肌细胞收缩性在缩性心肌病症下降,而不是增加. 这种收缩性赤字刺激导致高和纤维化的因素,解释了疾病的变异性.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 超性心肌病变 (HCM) 的特征是心脏过度缩小.
- 目前的理解表明,在HCM中心肌收缩性增加.
- 这项研究提出了HCM病变发生的替代假设.
研究的目的:
- 挑战目前普遍认为中华人民共和国人体收缩性增加的观点.
- 建议心肌细胞收缩性降低是HCM的主要缺陷.
- 将这种收缩性缺陷与心脏 trofhic 因素的表达以及随后的表型联系起来.
主要方法:
- 审查现有文献和提出的假设.
- 对来自HCM患者心脏肌细胞的基因转移研究的分析.
- 概念框架,将收缩性,热带因素和HCM表型联系起来.
主要成果:
- 基因转移研究支持HCM心肌中受损的收缩性和增加的热带因子表达.
- 假设认为,收缩性赤字驱动了摄食因子的增加,导致过度缩和纤维化.
- 奖杯因子表达的个体变异解释了HCM中的表型变异性.
结论:
- 心脏肌细胞收缩性降低可能是HCM的主要驱动因素.
- 由收缩性缺陷刺激的多发性因素是HCM表型的关键调解者.
- 需要进一步的研究来测量肌细胞收缩性,识别营养因子,并测试HCM的抑制策略.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


